Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry

Nature Protocols

Volumn 2, Issue 5, 2007, Pages 1152-1165

  Xing, Yun ^a   Chaudry, Qaiser ^b   Shen, Christopher ^a   Kong, Koon Yin ^b   Zhau, Haiyen E ^c   Chung, Leland W ^c   Petros, John A ^c,d   O'Regan, Ruth M ^c   Yezhelyev, Maksym V ^c   Simons, Jonathan W ^a,c   Wang, May D ^a,b,c   Nie, Shuming ^a,c  

^a Emory University   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; QUANTUM DOT;

ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; PARAMETER; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTIBODIES; BIOLOGICAL MARKERS; IMMUNOHISTOCHEMISTRY; QUANTUM DOTS; TISSUE CULTURE TECHNIQUES;

EID: 34250208736     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.107     Document Type: Article

References (55)

1. Bruchez, M. Jr., Moronne, M., Gin, P., Weiss, S. & Alivisatos, A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013-2015 (1998).
2. Chan, W.C.W. & Nie, S.M. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016-2018 (1998).
3. Alivisatos, P. The use of nanocrystals in biological detection. Nat. Biotechnol. 22, 47-52 (2004).
4. Pinaud, F. et al. Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 27, 1679-1687 (2006).
5. Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544 (2005).
6. Gao, X.H., Cui, Y.Y., Levenson, R.M., Chung, L.W.K. & Nie, S.M. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22, 969-976 (2004).
7. Smith, A.M., Gao, X.H. & Nie, S.M. Quantum dot nanocrystals for in vivo molecular and cellular imaging. Photochem. Photobiol. 80, 377-385 (2004).
8. Chan, W.C.W. et al. Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotechnol. 13 40-46 (2002).
9. Klostranec, J.M. & Chan, W.C.W. Quantum dots in biological and biomedical research: Recent progress and present challenges. Adv. Mater. 18, 1953-1964 (2006).
10. Medintz, I.L., Tetsuo-Uyeda, H., Goldman, E.R. & Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 4, 435-446 (2005).
11. Chattopadhyay, P.K. et al. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat. Med. 12, 972-977 (2006).
12. Yezhelyev, M. et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 7, 657-767 (2006).
13. Xing, Y., Smith, A.M., Agrawal, A., Ruan, G. & Nie, S.M. Profiling single cancer cells and clinical tissue specimens with semiconductor quantum dots. Int. J. Nanomed. 1, 473-481 (2006).
14. Gao, X.H. et al. In-vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol. 16, 63-72 (2005).
15. Wu, X.Y. et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21, 41-46 (2003).
16. Matsuno, A. et al. Three-dimensional imaging of the intracellular localization of growth hormone and prolactin and their mRNA using nanocrystal (quantum dot) and confocal laser scanning microscopy techniques. J. Histochem. Cytochem. 53, 833-838 (2005).
17. Giepmans, B.N.G. et al. Correlated light and electron microscopic imaging of multiple endogenous proteins using quantum dots. Nat. Methods 2, 743-749 (2005).
18. Ness, J.M. et al. Combined tyramide signal amplification and quantum dots for sensitive and photostable immunofluorescence detection. J. Histochem. Cytochem. 51, 981-987 (2003).
19. Nisman, R. et al. Application of quantum dots as probes for correlative fluorescence, conventional, and energy-filtered transmission electron microscopy. J Histochem. Cytochem. 52, 13-18 (2004).
20. Tokumasu, F. & Dvorak, J. Development and application of quantum dots for immunocytochemistry of human erythrocytes. J. Microsc. Oxford 211, 256-261 (2003).
21. Ghazani, A.A. et al. High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett. 6, 2881-2886 (2006).
22. Taylor, C.R. & Levenson, R.M. Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment II. Histopathology 49, 411-424 (2006).
23. Guarner, J. & Zaki, S.R. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents. J. Histochem. Cytochem. 54 3-11 (2006).
24. So, M.-K., Loening, A.M., Gambhir, S.S. & Rao, J.H. Creating self-illuminating quantum dot conjugates. Nat. Protoc. 1, 1160-1164 (2006).
25. Clapp, A.R., Goldman, E.R & Mattoussi, H. Capping of CdSe-ZnS quantum dots with DHLA and subsequent conjugation with proteins. Nat. Protocols 1, 1258-1266 (2006).
26. Bannai, H. et al. Imaging the lateral diffusion of membrane molecules with quantum dots. Nat. Protoc. 1, 2628-2634 (2007).
27. Goldman, E.R. et al. Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal. Chem. 74, 841-847 (2002).
28. Paborsky, L.R., Dunn, K.E., Gibbs, C.S. & Dougherty, J.P. A nickel chelate microtiter plate assay for six histidine-containing proteins. Anal. Biochem. 234, 60-65 (1996).
29. Jin, L. et al. Use of alpha-N,N bis[carboxymethyl]lysine-modified peroxidase in immunoassays. Anal. Biochem. 229, 54-60 (1995).
30. Shi, S.R., Cote, R.J. & Taylor, C.R. Antigen retrieval immunohistochemistry: Past, present, and future. J. Histochem. Cytochem. 45, 327-343 (1997).
31. Mortensen, E.N. & Barrett, W.A. Intelligent scissors for image composition. Proceedings of the 22nd Annual Conference on Computer Graphics and Interactive Techniques 191-198 (1995).
32. Hong, J.Y. & Wang, M.D. High speed processing of biomedical images using programmable GPU. Proc. IEEE Int. Conf. Image Processing (ICIP), Singapore 1133-1137 (2004).
33. Cormen, T.H., Leiserson, C.E., Rivest, R.L. & Stein, C. Introduction to Algorithms (MIT Press, Cambridge, MA, USA, 2001).
34. Weeks, A.R. & Hague, G.E. Color segmentation in the HSI color space using the K-means algorithm. Proc. SPIE - Nonlinear Image Processing VIII 143-154 (ACM Press, New York, USA, 1997).
35. Hermanson, G.T. Bioconjugate Techniques 475-478 (Academic, San Diego, CA, USA, 1996).
36. Hermanson, G.T. Bioconjugate Techniques, 123-124 (Academic, San Diego, CA, USA, 1996).
37. Huber, M.A., Kraut, N. & Beug, H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548-558 (2005).
38. Zhau, H.Y., Chang, S.M., Chen, B.Q., Wang, Y. & Zhang, H. Androgen-repressed phenotype in human prostate cancer. Proc. Natl. Acad. Sci. USA 93, 15152-15157 (1996).
39. Hernandez, I. et al. Prostate-specific expression of p53 (R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival. Mol. Cancer Res. 1, 1036-1047 (2003).
40. Mora, G.R., Olivier, K.R., Mitchell, R.F., Jenkins, R.B. & Tindall, D.J. Regulation of expression of the early growth response gene-1 (EGR-1 in malignant and benign cells of the prostate. Prostate 63, 198-207 (2005).
41. Mansfield, J.R., Gossage, K.W., Hoyt, C.C. & Levenson, R.M. Autofluorescence removal, multiplexing, and automated analysis methods for in-vivo fluorescence imaging. J. Biomed. Opt. 10, 41207 (2005).
42. Levenson, R.M. Spectral imaging and pathology: Seeing more. Lab. Med. 35, 244-252 (2004).
43. Umemura, S. & Osamura, R.Y. Utility of immunohistochemistry in breast cancer practice. Breast Cancer 11, 334-338 (2004).
44. Thomson, A. et al. HER-2/neu in breast cancer: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization. Mod. Pathol. 14, 1079-1086 (2001).
45. Vogel, C.L. et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J. Clin. Oncol. 20, 719-726 (2002).
46. Elledge, R.M. et al. Estrogen receptor (ER) and progesterone receptor (PR), by ligand-binding assay compared with ER, PR and pS2, by immunohistochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group Study. Int. J. Cancer 89, 111-117 (2000).
47. Marquez, D.C. & Pietras, R.J. Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20, 5420-5430 (2001).
48. Hicks, D.G. & Tubbs, R.R. Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: A technical review with interpretive guidelines. Hum. Pathol. 36, 250-261 (2005).
49. Konecny, G. et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J. Natl. Cancer Inst. 95, 142-153 (2003).
50. Matkowskyj, K.A., Schonfeld, D. & Benya, R.V. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software Photoshop and Matlab. J. Histochem. Cytochem. 48, 303-311 (2000).
51. Matkowskyj, K.A., Schonfeld, D. & Benya, R.V. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J. Histochem. Cytochem. 51, 205-214 (2003).
52. Bailey, R.E. & Nie, S.M. Alloyed semiconductor QDs: Tuning the optical properties without changing the particle size. J. Am. Chem. Soc. 125, 7100-7106 (2003).
53. Jiang, W., Singhal, A., Zheng, J.N., Wang, C. & Chan, W.C.W. Optimizing the synthesis of red- to near-IR-emitting CdS-capped CdTexSe1-x alloyed quantum dots for biomedical imaging. Chem. Mater. 18, 4845-4854 (2006).
54. Zhong, X.H., Han, M.Y., Dong, Z.L., White, T.J. & Knoll, W. Composition-tunable ZnxCd1-xSe nanocrystals with high luminescence and stability. J. Am. Chem. Soc. 125, 8589-8594 (2003).
55. Zhong, X.H., Feng, Y.Y., Knoll, W. & Han, M.Y. Alloyed ZnxCd1-xS nanocrystals with highly narrow luminescence spectral width. J. Am. Chem. Soc. 125, 13559-13563 (2003).